Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Early trial tests One-Shot pain relief for advanced bone cancer

NCT ID NCT07197645

Summary

This early-phase study is testing a single injection of an experimental drug called TLX090-Tx. It aims to see if the treatment is safe and can reduce pain in people with advanced cancer that has spread to their bones. The study will enroll 33 participants who have significant bone pain that hasn't responded well to other treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES IN SUBJECTS WITH ADVANCED CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Excel Diagnostics and Nuclear Oncology Center

    RECRUITING

    Houston, Texas, 77042, United States

    Contact Email: •••••@•••••

    Contact

  • Houston Metro Urology

    RECRUITING

    Houston, Texas, 77027, United States

    Contact Email: •••••@•••••

    Contact

  • Oncology Consultants

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.